Impact of COVID19 on Asthma

Study Overview
=================
Brief Summary
-----------------
The COVID19 pandemic is having an immeasurable impact on the economy and on morbidity and mortality. Knowledge and scientific evidence about this disease is advancing rapidly, but it is not yet known whether asthmatic patients suffering from COVID19 have an exacerbation of asthma, or whether this viral infection has an impact on control and lung function in the short to medium term. The aim of this study is to define the changes that occur in these two parameters in asthmatic patients suffering from COVID19. To this end, asthmatic patients who have suffered a SARS-CoV-2 infection and who have required an emergency consultation or hospitalisation will be collected in a pneumology consultation and matched by age, sex and severity of asthma with a group that has not suffered the same. Both will be followed for one year, and lung function will be tested at six months and exacerbations and changes in ACT during the following year. These data are intended to improve the available knowledge on the impact of IDVC19 on asthma patients with a view to making appropriate recommendations, prevention and treatment adjustments in line with the results obtained.

Official Title
-----------------
Impact of COVID19 on Lung Function and Control of Asthma Patients

Conditions
-----------------
Asthma, Covid19

Intervention / Treatment
-----------------
* Diagnostic Test: spirometry
* Other: Asthma control test


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 12 -80 years Asthma diagnosis according to guidelines Follow up on asthma clinics in one of the participant hospitals Exclusion Criteria: Other severe respiratory condition independent of asthma

Ages Eligible for Study
-----------------
Minimum Age: 12 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Asthma and COVID19 infection<br>Asthma and COVID19 infection | Diagnostic Test: spirometry<br>* Lung function test: pre and post bronchodilator spirometry<br>Other: Asthma control test<br>* Asthma control test<br>|
| Asthma without COVID19 infection<br>Asthma and COVID19 infection | Diagnostic Test: spirometry<br>* Lung function test: pre and post bronchodilator spirometry<br>Other: Asthma control test<br>* Asthma control test<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Asthma control | Change in score of Asthma Control Test (ACT). Min 5 máx 25 (the higher score indicates better control) | 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Asthma function | Change in FEV1 (Forced expiratory volume in one second) | 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
asthma, asthma control, COVID19